Find a Clinic Near You And Get Started Today


You are here

IVF Trials Boost for BlueGnome

Business Weekly,  May 3, 2012

Results of a new study show that technology from BlueGnome in Cambridge can offer “dramatic benefit to IVF success,” the UK company has revealed.
BlueGnome unveiled the results of the first randomised prospective IVF study of pre-implantation chromosome analysis using its 24sure array platform.
The study, published in The Journal of Molecular Cytogenetics by Yang et al (Pacific Reproductive Center,Torrance, USA) has demonstrated that selectively implanting euploid embryos, with a normal number of chromosomes, significantly increases pregnancy rates.

Read more.


Add new comment

By submitting this form, you accept the Mollom privacy policy.